Rosabulin

N/A

Report date: 2024/05/07 20:00:09
NME

Base Information

Drug NameRosabulin
Drug Alias Name罗沙布林rosabulinarosabuline洛沙布林rosabulinum +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsLymphoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMadrigal Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMadrigal Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursHematologic NeoplasmsLymphoma +[4] 

Other Information

ATC CodeN/A
Related LinksKEGG